12 years treating AML
Dr. Jonas focuses his research on acute myeloid leukemia, myelodysplastic syndrome, acute lymphoblastic leukemia and other hematologic malignancies. His clinical and translational research focuses on the development and application of novel therapeutic agents for acute leukemias and MDS. In particular, Dr. Jonas is interested in leukemia stem cell biology and development of novel aniti-leukemia stem cell therapeutics.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.
Terms of Use and Privacy Policy Newsroom About Donations Find an AML Specialist Newsletter Learn Connect
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811